Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma

被引:100
作者
Hillen, Femke [1 ]
Baeten, Coen I. M. [1 ]
van de Winkel, Anouk [1 ]
Creytens, David [1 ]
van der Schaft, Daisy W. J. [1 ]
Winnepenninckx, Veronique [1 ]
Griffioen, Arjan W. [1 ]
机构
[1] Univ Hosp Maastricht, Angiogenesis Lab, Dept Pathol, Res Inst Grow & Dev, NL-6202 AZ Maastricht, Netherlands
关键词
tumor infiltrating leukocytes; prognosis; immunosuppression; activation status of lymphocytes; angiogenesis; tumor cell plasticity; cutaneous melanoma;
D O I
10.1007/s00262-007-0353-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Various clinical and experimental observations detected an immunological host defense in cutaneous melanoma. In order to investigate the prognostic value of leukocyte effector mechanisms, we examined the presence of different subsets of leukocytes in tumor samples of 58 patients diagnosed with primary cutaneous melanoma. The presence of T lymphocytes, cytotoxic T lymphocytes, B lymphocytes, CD16+ cells and macrophages was correlated to Breslow depth. A significantly higher amount of several subsets of leukocytes was found in samples with a more progressed tumor stage and survival analysis demonstrated that a higher amount of T lymphocytes and CD16+ cells was associated with a short survival. The amount of FOXP3+ regulatory T lymphocytes did not correlate with survival, nevertheless, it correlated with the amount of total infiltrate. In contrast, analysis of the expression of CD69, a marker for activated lymphocytes, demonstrated that patients with a higher amount of CD69+ lymphocytes had a better survival. In addition, a new parameter for aggressiveness of melanoma, tumor cell plasticity [i.e., the presence of periodic acid Schiff's (PAS) reagent positive loops], also predicted short survival and a trend of a higher amount of tumor infiltrating leukocytes in tumors with PAS positive loops was observed. These findings demonstrate that leukocyte infiltration and the presence of PAS loops is a sign of tumor aggressiveness and may have prognostic value.
引用
收藏
页码:97 / 106
页数:10
相关论文
共 79 条
  • [1] IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients
    Ahmadzadeh, M
    Rosenberg, ST
    [J]. BLOOD, 2006, 107 (06) : 2409 - 2414
  • [2] Depletion of normal B cells with rituximab as an adjunct to IL-2 therapy for renal cell carcinoma and melanoma
    Aklilu, M
    Stadler, WM
    Markiewicz, M
    Vogelzang, NJ
    Mahowald, M
    Johnson, M
    Gajewski, TF
    [J]. ANNALS OF ONCOLOGY, 2004, 15 (07) : 1109 - 1114
  • [3] Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells
    Alvaro, T
    Lejeune, M
    Salvadó, MT
    Bosch, R
    García, JF
    Jaén, J
    Banham, AH
    Roncador, G
    Montalbán, C
    Piris, MA
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (04) : 1467 - 1473
  • [4] New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site
    Appay, Victor
    Jandus, Camilla
    Voelter, Verena
    Reynard, Severine
    Coupland, Sarah E.
    Rimoldi, Donata
    Lienard, Danielle
    Guillaume, Philippe
    Krieg, Arthur M.
    Cerottini, Jean-Charles
    Romero, Pedro
    Leyvraz, Serge
    Rufer, Nathalie
    Speiser, Daniel E.
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 177 (03) : 1670 - 1678
  • [5] Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers
    Badoual, C
    Hans, S
    Rodriguez, J
    Peyrard, S
    Klein, C
    Agueznay, NE
    Mosseri, V
    Laccourreye, O
    Bruneval, P
    Fridman, WH
    Brasnu, DF
    Tartour, E
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (02) : 465 - 472
  • [6] Barnhill RL, 1996, CANCER-AM CANCER SOC, V78, P427
  • [7] Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse
    Bates, Gaynor J.
    Fox, Stephen B.
    Han, Cheng
    Leek, Russell D.
    Garcia, Jose F.
    Harris, Adrian L.
    Banham, Alison H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (34) : 5373 - 5380
  • [8] B cells directly tolerize CD8+ T cells
    Bennett, SRM
    Carbone, FR
    Toy, T
    Miller, JFAP
    Heath, WR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (11) : 1977 - 1983
  • [9] The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies
    Bingle, L
    Brown, NJ
    Lewis, CE
    [J]. JOURNAL OF PATHOLOGY, 2002, 196 (03) : 254 - 265
  • [10] HISTOLOGICAL REGRESSION IN PRIMARY CUTANEOUS MELANOMA - RECOGNITION, PREVALENCE AND SIGNIFICANCE
    BLESSING, K
    MCLAREN, KM
    [J]. HISTOPATHOLOGY, 1992, 20 (04) : 315 - 322